Literature DB >> 21160767

Telomere function in colorectal cancer.

Cristina Frías1, Alberto Morán, Carmen de Juan, Paloma Ortega, Tamara Fernández-Marcelo, Andrés Sánchez-Pernaute, Antonio José Torres, Eduardo Díaz-Rubio, Manuel Benito, Pilar Iniesta.   

Abstract

Colorectal cancer is the third most common form of cancer and the second leading cause of cancer-related death in the western world. Tumour cells acquire the hallmarks of cancer during the carcinogenic selection process. Cell immortality is one of the principal features acquired during this process which involves the stabilization of telomere length. It is achieved mainly, by telomerase activation. Thus, the discovery of telomeres and telomerase allowed an understanding of the mechanisms by which cells can become immortalized. Different studies have shown that tumour cells have shorter telomeres than nontumour cells and have detected telomerase activity in the majority of tumours. Survival studies have determined that telomere maintenance and telomerase activity are associated with poor prognosis. Taking into account all the results achieved by different groups, quantification and evaluation of telomerase activity and measurement of telomere length may be useful methods for additional biologic and prognostic staging of colorectal carcinoma.

Entities:  

Keywords:  Colorectal cancer; Immortality; Telomeres

Year:  2009        PMID: 21160767      PMCID: PMC2999092          DOI: 10.4251/wjgo.v1.i1.3

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  79 in total

1.  Cancer. Telomerase meets its mismatch.

Authors:  R Kucherlapati; R A DePinho
Journal:  Nature       Date:  2001-06-07       Impact factor: 49.962

2.  The Stability of Broken Ends of Chromosomes in Zea Mays.

Authors:  B McClintock
Journal:  Genetics       Date:  1941-03       Impact factor: 4.562

Review 3.  Telomerase and chromosome end maintenance.

Authors:  J Lingner; T R Cech
Journal:  Curr Opin Genet Dev       Date:  1998-04       Impact factor: 5.578

4.  Telomerase activity in stage II colorectal carcinoma.

Authors:  Rika Kawanishi-Tabata; Francisco Lopez; Sam Fratantonio; Nam Kim; John Goldblum; Raymond Tubbs; Paul Elson; Ian Lavery; Ronald M Bukowski; Ram Ganapathi; Mahrukh K Ganapathi
Journal:  Cancer       Date:  2002-11-01       Impact factor: 6.860

5.  Origin of concatemeric T7 DNA.

Authors:  J D Watson
Journal:  Nat New Biol       Date:  1972-10-18

6.  hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.

Authors:  M Meyerson; C M Counter; E N Eaton; L W Ellisen; P Steiner; S D Caddle; L Ziaugra; R L Beijersbergen; M J Davidoff; Q Liu; S Bacchetti; D A Haber; R A Weinberg
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

Review 7.  Epidemiology, disease progression, and economic burden of colorectal cancer.

Authors:  Al B Benson
Journal:  J Manag Care Pharm       Date:  2007-08

8.  Telomerase activity of blood samples and recurrence of colorectal cancer.

Authors:  Tatsuya Ohnishi; Toshiaki Watanabe; Hiroaki Nozawa; Joji Kitayama; Hirokazu Nagawa
Journal:  Hepatogastroenterology       Date:  2008 Sep-Oct

9.  Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer.

Authors:  A Ghori; B Usselmann; S Ferryman; A Morris; I Fraser
Journal:  Colorectal Dis       Date:  2002-11       Impact factor: 3.788

Review 10.  Telomerase and cancer therapeutics.

Authors:  Calvin B Harley
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

View more
  4 in total

1.  The relationship between telomere length and clinicopathologic characteristics in colorectal cancers among Tunisian patients.

Authors:  Raja Mzahma; Maher Kharrat; Fadhel Fetiriche; Mounir Ben Moussa; Zoubeir Ben Safta; Chadli Dziri; AbdelJelil Zaouche; Habiba Chaabouni-Bouhamed
Journal:  Tumour Biol       Date:  2015-06-06

2.  Genetic and lifestyle influence on telomere length and subsequent risk of colon cancer in a case control study.

Authors:  Andrew J Pellatt; Roger K Wolff; Abbie Lundgreen; Richard Cawthon; Martha L Slattery
Journal:  Int J Mol Epidemiol Genet       Date:  2012-08-31

Review 3.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869

4.  Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer.

Authors:  R Bertorelle; M Briarava; E Rampazzo; L Biasini; M Agostini; I Maretto; S Lonardi; M L Friso; C Mescoli; V Zagonel; D Nitti; A De Rossi; S Pucciarelli
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.